Serotonin receptor 4 agonism prevents high fat diet induced reduction in GLP-1 in mice
European Journal of Pharmacology · 2023-12 · 960 · 176181
DOI: 10.1016/j.ejphar.2023.176181 ↗Kurz gefasst
Fachartikel in der Zeitschrift European Journal of Pharmacology, 2023-12. Verfasst von Amanda Marie Vanslette und 4 weiteren Autor:innen. Beteiligte Einrichtung: Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denm…. Hauptthemen laut MEDLINE: Glucagon-Like Peptide 1, Diet, High-Fat. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 39 Literaturangaben. Gefördert von: Novo Nordisk Fonden.
Abstract (Originalsprache)
Hormone-producing enteroendocrine cells (EECs) are present throughout the gastrointestinal tract and respond to various nutrient and gut microbiota produced metabolites stimuli. Two important EEC subtypes, Glucagon like peptide-1 (GLP-1) producing L-cells and serotonin (5-HT) producing enterochromaffin (EC) cells interact via paracrine signaling and exhibit bidirectional regulation of expression and secretion of produced hormones. Accordingly, in vitro studies suggest potential to modulate 5-HT secretion by GLP-1 receptor agonism, and L-cell differentiation via serotonin receptor 4 agonism. However, the importance of this cellular signaling on host metabolism is poorly understood. In this study, we found that two weeks of high fat diet (HFD) feeding reduced RNA expression of gut hormones, including proglucagon (Gcg) gene encoding GLP-1 and Tryptophan hydroxylase1 (Tph1) gene encoding rate limiting enzyme in 5-HT synthesis, specifically in the colon and reduced plasma GLP-1 levels. Levels of propionate and butyrate were also reduced following HFD. However, supplementation of sodium propionate did not improve HFD induced reduction in GLP-1. In contrast, chemical induction of serotonin receptor 4 promoted GLP-1 levels, colonic Gcg RNA expression accompanied by improvement in glucose tolerance in HFD-fed mouse. Thus, this study suggests a novel mechanism to improve glucose tolerance via serotonin receptor 4 stimulation in the HFD induced obese mouse model.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark.
- Human Health Research, Scientific Affairs, Chr. Hansen A/S, Bøge Alle 10-12, 2970, Hørsholm, Denmark.
- Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, 2200, Copenhagen, Denmark. Electronic address: arora@sund.ku.dk.
Förderung
- Novo Nordisk Fonden
Zitieren
APA
Vanslette, A. M., Toft, P. B., Lund, M. L., Moritz, T., & Arora, T. (2023). Serotonin receptor 4 agonism prevents high fat diet induced reduction in GLP-1 in mice. European Journal of Pharmacology, 960, 176181. https://doi.org/10.1016/j.ejphar.2023.176181
Vancouver
Vanslette AM, Toft PB, Lund ML, Moritz T, Arora T. Serotonin receptor 4 agonism prevents high fat diet induced reduction in GLP-1 in mice. European Journal of Pharmacology. 2023;960:176181. doi:10.1016/j.ejphar.2023.176181
BibTeX
@article{Vanslette2023,
author = {Vanslette, Amanda Marie and Toft, Pernille Baumann and Lund, Mari Lilith and Moritz, Thomas and Arora, Tulika},
title = {Serotonin receptor 4 agonism prevents high fat diet induced reduction in GLP-1 in mice},
journal = {European Journal of Pharmacology},
year = {2023},
volume = {960},
pages = {176181},
doi = {10.1016/j.ejphar.2023.176181}
}
EUVIMED